Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-01

AUTHORS

P-E Heudel, M Fabbro, C Roemer-Becuwe, M C Kaminsky, A Arnaud, F Joly, S Roche-Forestier, J Meunier, C Foa, B You, F Priou, Y Tazi, A Floquet, F Selle, D Berton-Rigaud, A Lesoin, E Kalbacher, A Lortholary, L Favier, I Treilleux, I Ray-Coquard

ABSTRACT

Backround:Patients with metastatic endometrial carcinoma have a poor prognosis and PIK3CA mutations and amplifications are common in these cancers. This study evaluated the efficacy and safety of the pure PI3K inhibitor BKM120 in advanced or recurrent endometrial carcinoma. METHODS: This phase II, multicentre, single-arm, double strata (histological low grade (LG) or high grade (HG)) open-label study enrolled patients with histologically confirmed advanced or recurrent endometrial carcinoma who had received not more than one prior chemotherapy regimen. Patients received initially BKM120 100 mg tablets once daily. Primary end points were proportion of patients free of progression at 2 months (HG strata) or at 3 months (LG strata), objective response rate (ORR), and safety. RESULTS: A total of 40 patients were enrolled, of whom 16 patients had received BKM120 at 100 mg. Because of high toxicities (cutaneous rash (54%), depressive events (47%), and anxiety (40%), the IDMC has proposed to stop recruitment at 100 mg and to continue the clinical trial with a lower dose of 60 mg per day. In addition, 24 patients (median age 67 years old) were newly enrolled (14 in the LG strata and 10 in the HG strata). Rate of nonprogression at 2 months in the HG strata was 70% and at 3 months was 60% in the LG strata. Median progression-free survival (PFS) for all patients is 4.5 months (CI 95% 2.8-6.1), and the median PFS for LG strata is 8.3 months compared with 3.8 months for the HG strata. No response was reported. At 60 mg per day, the most commonly reported treatment-related adverse events (AEs) were hyperglycaemia (58%), cognitive (31%), digestive (28%), hepatic liver functions (26%), and rash (23%). The most commonly reported treatment-related grade ⩾3 AEs were HTA (17%), hyperglycaemia (17%), and increased alanine aminotransferase (24%). Five patients (21%) stopped BKM120 for toxicity. CONCLUSIONS: The BKM120 was associated with an unfavourable safety profile and minimal antitumour activity in monotherapy in advanced or recurrent endometrial carcinoma. The clinical trial was stopped before end of recruitment for toxicity. More... »

PAGES

303

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2016.430

DOI

http://dx.doi.org/10.1038/bjc.2016.430

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049733476

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28072765


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aminopyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Endometrioid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endometrial Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Morpholines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphatidylinositol 3-Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Center of Lyon", 
          "id": "https://www.grid.ac/institutes/grid.462282.8", 
          "name": [
            "Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Centre de Recherche en Canc\u00e9rologie de Lyon, 28 Rue Laennec, 69008 Lyon, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heudel", 
        "givenName": "P-E", 
        "id": "sg:person.01046414414.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046414414.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "UniCancer Group", 
          "id": "https://www.grid.ac/institutes/grid.418189.d", 
          "name": [
            "ICM Val d'Aurelle, Parc Eurom\u00e9decine 208 Rue des Apothicaires, 34298 Montpellier, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fabbro", 
        "givenName": "M", 
        "id": "sg:person.0673616572.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673616572.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ORACLE Centre d'oncologie de Gentilly, 2 Rue Marie Marvingt, 54100 Nancy, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roemer-Becuwe", 
        "givenName": "C", 
        "id": "sg:person.01176376555.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176376555.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut de Canc\u00e9rologie de Lorraine", 
          "id": "https://www.grid.ac/institutes/grid.452436.2", 
          "name": [
            "ICL Institut de Canc\u00e9rologie de Lorraine, 6 Avenue de Bourgogne Brabois, 54511 Vandoeuvre-les-Nancy, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaminsky", 
        "givenName": "M C", 
        "id": "sg:person.0725456003.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725456003.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Sainte Catherine", 
          "id": "https://www.grid.ac/institutes/grid.482015.a", 
          "name": [
            "Institut Sainte Catherine, 250 Chemin de Baigne-pieds, 84918 Avignon, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arnaud", 
        "givenName": "A", 
        "id": "sg:person.0603333673.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603333673.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Franois Baclesse", 
          "id": "https://www.grid.ac/institutes/grid.476192.f", 
          "name": [
            "Centre Fran\u00e7ois Baclesse, Avenue du G\u00e9n\u00e9ral Harris, 14000 Caen, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joly", 
        "givenName": "F", 
        "id": "sg:person.01130240530.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130240530.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Jean Bernard", 
          "id": "https://www.grid.ac/institutes/grid.477089.5", 
          "name": [
            "Centre Jean Bernard-Clinique Victor Hugo, 18 Rue Victor Hugo, 72000 Le Mans, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roche-Forestier", 
        "givenName": "S", 
        "id": "sg:person.01310114005.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310114005.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre hospitalier r\u00e9gional d'Orl\u00e9ans", 
          "id": "https://www.grid.ac/institutes/grid.413932.e", 
          "name": [
            "Centre hospitalier r\u00e9gional d'Orl\u00e9ans, 14 Avenue de l'H\u00f4pital, 45067 Orl\u00e9ans, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meunier", 
        "givenName": "J", 
        "id": "sg:person.0713113255.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713113255.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital priv\u00e9 Clairval", 
          "id": "https://www.grid.ac/institutes/grid.418122.c", 
          "name": [
            "H\u00f4pital priv\u00e9 Clairval, 317 Boulevard du Redon, 13009 Marseille, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Foa", 
        "givenName": "C", 
        "id": "sg:person.01040472216.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040472216.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Lyon Sud", 
          "id": "https://www.grid.ac/institutes/grid.411430.3", 
          "name": [
            "Centre hospitalier Lyon Sud, 165 Chemin du Grand Revoyet, 69495 Pierre-B\u00e9nite, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "You", 
        "givenName": "B", 
        "id": "sg:person.0653052265.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653052265.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Centre hospitalier d\u00e9partemental Les Oudairies, Les Oudairies, 85925 La Roche-sur-Yon, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Priou", 
        "givenName": "F", 
        "id": "sg:person.01302261163.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302261163.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Institut de canc\u00e9rologie Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tazi", 
        "givenName": "Y", 
        "id": "sg:person.01160553765.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160553765.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Bergoni\u00e9", 
          "id": "https://www.grid.ac/institutes/grid.476460.7", 
          "name": [
            "Institut Bergoni\u00e9, 229 Cours de l'Argonne, 33076 Bordeaux, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Floquet", 
        "givenName": "A", 
        "id": "sg:person.01303347205.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303347205.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tenon Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413483.9", 
          "name": [
            "H\u00f4pital Tenon, 4 rue de la Chine 75020 Paris, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Selle", 
        "givenName": "F", 
        "id": "sg:person.0723166073.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723166073.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ICO centre Ren\u00e9 Gauducheau, Boulevard Jacques Monod, 44805 Saint Herblain, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berton-Rigaud", 
        "givenName": "D", 
        "id": "sg:person.0602102643.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602102643.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Oscar Lambret", 
          "id": "https://www.grid.ac/institutes/grid.452351.4", 
          "name": [
            "Centre Oscar Lambret, 3 Rue F. Combemale, 59020 Lille, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lesoin", 
        "givenName": "A", 
        "id": "sg:person.0676173315.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676173315.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Besan\u00e7on", 
          "id": "https://www.grid.ac/institutes/grid.411158.8", 
          "name": [
            "H\u00f4pital Jean Minjoz, 3 Boulevard Alexandre Fleming, 25030 Besan\u00e7on, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kalbacher", 
        "givenName": "E", 
        "id": "sg:person.0770700432.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770700432.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Confluent Private Hospital", 
          "id": "https://www.grid.ac/institutes/grid.490056.e", 
          "name": [
            "Centre Catherine de Sienne, 2 Rue Eric Tabarly, 44202 Nantes, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lortholary", 
        "givenName": "A", 
        "id": "sg:person.01130363736.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130363736.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Georges Fran\u00e7ois Leclerc", 
          "id": "https://www.grid.ac/institutes/grid.418037.9", 
          "name": [
            "Centre Georges Fran\u00e7ois Leclerc, 1 Rue Professeur Marion, 21079 Dijon, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Favier", 
        "givenName": "L", 
        "id": "sg:person.0771464734.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771464734.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Center of Lyon", 
          "id": "https://www.grid.ac/institutes/grid.462282.8", 
          "name": [
            "Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Centre de Recherche en Canc\u00e9rologie de Lyon, 28 Rue Laennec, 69008 Lyon, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Treilleux", 
        "givenName": "I", 
        "id": "sg:person.01210131470.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210131470.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Claude Bernard University Lyon 1", 
          "id": "https://www.grid.ac/institutes/grid.7849.2", 
          "name": [
            "Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Centre de Recherche en Canc\u00e9rologie de Lyon, 28 Rue Laennec, 69008 Lyon, France.", 
            "UCBL Universit\u00e9 Claude Bernard, Lyon I, Lyon, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ray-Coquard", 
        "givenName": "I", 
        "id": "sg:person.01011732622.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011732622.02"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3747/co.22.2393", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001818806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/gyno.2000.5865", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005662943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0000000000000607", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006459485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-10-0540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007254509"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.humpath.2010.01.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007351676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.58.3401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007930689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.25516", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008443664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.25516", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008443664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2014.12.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009130095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012105008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2014.06.033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016795262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.58.8871", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022817141"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.00897.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025011674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.00897.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025011674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2014.01.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025790666"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11523-012-0242-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031547406", 
          "https://doi.org/10.1007/s11523-012-0242-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2008.01.028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034647261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl417", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035040603"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.34.1578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036050400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70591-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037614110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.54.0518", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038582973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2013.183", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041756285", 
          "https://doi.org/10.1038/bjc.2013.183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2013.59", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042426230", 
          "https://doi.org/10.1038/bjc.2013.59"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.36.1360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045236478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0020-7292(06)60031-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045288298"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.0708", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046132060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.11.861", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049096878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jcp.2008.056101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049314556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2010.08.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050434269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(89)90015-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053744925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(89)90015-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053744925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ijo.25.6.1615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071515520"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-01", 
    "datePublishedReg": "2017-01-01", 
    "description": "Backround:Patients with metastatic endometrial carcinoma have a poor prognosis and PIK3CA mutations and amplifications are common in these cancers. This study evaluated the efficacy and safety of the pure PI3K inhibitor BKM120 in advanced or recurrent endometrial carcinoma.\nMETHODS: This phase II, multicentre, single-arm, double strata (histological low grade (LG) or high grade (HG)) open-label study enrolled patients with histologically confirmed advanced or recurrent endometrial carcinoma who had received not more than one prior chemotherapy regimen. Patients received initially BKM120 100\u2009mg tablets once daily. Primary end points were proportion of patients free of progression at 2 months (HG strata) or at 3 months (LG strata), objective response rate (ORR), and safety.\nRESULTS: A total of 40 patients were enrolled, of whom 16 patients had received BKM120 at 100\u2009mg. Because of high toxicities (cutaneous rash (54%), depressive events (47%), and anxiety (40%), the IDMC has proposed to stop recruitment at 100\u2009mg and to continue the clinical trial with a lower dose of 60\u2009mg per day. In addition, 24 patients (median age 67 years old) were newly enrolled (14 in the LG strata and 10 in the HG strata). Rate of nonprogression at 2 months in the HG strata was 70% and at 3 months was 60% in the LG strata. Median progression-free survival (PFS) for all patients is 4.5 months (CI 95% 2.8-6.1), and the median PFS for LG strata is 8.3 months compared with 3.8 months for the HG strata. No response was reported. At 60\u2009mg per day, the most commonly reported treatment-related adverse events (AEs) were hyperglycaemia (58%), cognitive (31%), digestive (28%), hepatic liver functions (26%), and rash (23%). The most commonly reported treatment-related grade \u2a7e3 AEs were HTA (17%), hyperglycaemia (17%), and increased alanine aminotransferase (24%). Five patients (21%) stopped BKM120 for toxicity.\nCONCLUSIONS: The BKM120 was associated with an unfavourable safety profile and minimal antitumour activity in monotherapy in advanced or recurrent endometrial carcinoma. The clinical trial was stopped before end of recruitment for toxicity.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.2016.430", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "116"
      }
    ], 
    "name": "Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I\u2013type II study from the GINECO group", 
    "pagination": "303", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ece9ddc00c1fa6bad3cf389cff939c16ab9c66c7aa820a428d8d3056dbbfac5a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28072765"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2016.430"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049733476"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2016.430", 
      "https://app.dimensions.ai/details/publication/pub.1049733476"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000434.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc2016430"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2016.430'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2016.430'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2016.430'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2016.430'


 

This table displays all metadata directly associated to this object as RDF triples.

421 TRIPLES      21 PREDICATES      75 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2016.430 schema:about N0cdd54ae26c5451c88ad5c68f3b766ab
2 N2ab16bc2f2ab4bdcb7d52cad7888cd81
3 N2b00b32909884e3685d2c9aa9b736fa2
4 N405fa3e49e924f8ba60c4a944f8364e5
5 N59948e06cd1046f49a3755942df122ff
6 N61353444f24f42c5932ce41c3375c38e
7 N623dc783a4414aa49f769fc2afb7ebf8
8 N62bbe598cdce410db82d04fbfe33862e
9 N8282e895d9fa4d898d0799e4ae8e8f0a
10 N9358172417c44cffac76a24eddcad0db
11 N9b4e04e8a5c14c37b1f3d7f79b482d3f
12 Nb6788536af544a30bccf3a9a616209f8
13 Nc28dafc75bd74ff289f68f90833e5675
14 Nc5dd7ebd21764dee8565b5774905deb7
15 Nc68075646e974580b71cc8d41d6c42dd
16 Nf270d8e8e2bd4cc38192a2118d6b05e8
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author Na25a5a62f5254aa4b294389e97324cc6
20 schema:citation sg:pub.10.1007/s11523-012-0242-9
21 sg:pub.10.1038/bjc.2013.183
22 sg:pub.10.1038/bjc.2013.59
23 https://doi.org/10.1002/cncr.25515
24 https://doi.org/10.1002/ijc.25516
25 https://doi.org/10.1006/gyno.2000.5865
26 https://doi.org/10.1016/0197-2456(89)90015-9
27 https://doi.org/10.1016/j.humpath.2010.01.030
28 https://doi.org/10.1016/j.ygyno.2008.01.028
29 https://doi.org/10.1016/j.ygyno.2010.08.025
30 https://doi.org/10.1016/j.ygyno.2014.01.015
31 https://doi.org/10.1016/j.ygyno.2014.06.033
32 https://doi.org/10.1016/j.ygyno.2014.12.019
33 https://doi.org/10.1016/s0020-7292(06)60031-3
34 https://doi.org/10.1016/s1470-2045(13)70591-6
35 https://doi.org/10.1093/annonc/mdl417
36 https://doi.org/10.1093/jnci/92.11.861
37 https://doi.org/10.1093/jnci/92.3.205
38 https://doi.org/10.1097/jto.0000000000000607
39 https://doi.org/10.1111/j.1525-1438.2007.00897.x
40 https://doi.org/10.1136/jcp.2008.056101
41 https://doi.org/10.1158/1078-0432.ccr-10-0540
42 https://doi.org/10.1200/jco.2010.34.1578
43 https://doi.org/10.1200/jco.2011.36.1360
44 https://doi.org/10.1200/jco.2011.39.0708
45 https://doi.org/10.1200/jco.2013.54.0518
46 https://doi.org/10.1200/jco.2014.58.3401
47 https://doi.org/10.1200/jco.2014.58.8871
48 https://doi.org/10.3747/co.22.2393
49 https://doi.org/10.3892/ijo.25.6.1615
50 schema:datePublished 2017-01
51 schema:datePublishedReg 2017-01-01
52 schema:description Backround:Patients with metastatic endometrial carcinoma have a poor prognosis and PIK3CA mutations and amplifications are common in these cancers. This study evaluated the efficacy and safety of the pure PI3K inhibitor BKM120 in advanced or recurrent endometrial carcinoma. METHODS: This phase II, multicentre, single-arm, double strata (histological low grade (LG) or high grade (HG)) open-label study enrolled patients with histologically confirmed advanced or recurrent endometrial carcinoma who had received not more than one prior chemotherapy regimen. Patients received initially BKM120 100 mg tablets once daily. Primary end points were proportion of patients free of progression at 2 months (HG strata) or at 3 months (LG strata), objective response rate (ORR), and safety. RESULTS: A total of 40 patients were enrolled, of whom 16 patients had received BKM120 at 100 mg. Because of high toxicities (cutaneous rash (54%), depressive events (47%), and anxiety (40%), the IDMC has proposed to stop recruitment at 100 mg and to continue the clinical trial with a lower dose of 60 mg per day. In addition, 24 patients (median age 67 years old) were newly enrolled (14 in the LG strata and 10 in the HG strata). Rate of nonprogression at 2 months in the HG strata was 70% and at 3 months was 60% in the LG strata. Median progression-free survival (PFS) for all patients is 4.5 months (CI 95% 2.8-6.1), and the median PFS for LG strata is 8.3 months compared with 3.8 months for the HG strata. No response was reported. At 60 mg per day, the most commonly reported treatment-related adverse events (AEs) were hyperglycaemia (58%), cognitive (31%), digestive (28%), hepatic liver functions (26%), and rash (23%). The most commonly reported treatment-related grade ⩾3 AEs were HTA (17%), hyperglycaemia (17%), and increased alanine aminotransferase (24%). Five patients (21%) stopped BKM120 for toxicity. CONCLUSIONS: The BKM120 was associated with an unfavourable safety profile and minimal antitumour activity in monotherapy in advanced or recurrent endometrial carcinoma. The clinical trial was stopped before end of recruitment for toxicity.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree true
56 schema:isPartOf N6b581f54378e4847a87673cd1f159c8c
57 N9924032479434462a6ce29411a60332f
58 sg:journal.1017082
59 schema:name Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group
60 schema:pagination 303
61 schema:productId N6326b10f76654966b4a8a28d3125f263
62 N63469cdf19f04fd5a685bd16cd2ddcb4
63 N9f59f194ce3f4f53a2db1a8ea5d50763
64 Naca1a78b2ed3441f9c471153ff5642e8
65 Nc4fdefc8f5ae4a29966f5469e03698fe
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049733476
67 https://doi.org/10.1038/bjc.2016.430
68 schema:sdDatePublished 2019-04-10T21:25
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher Nc1af2d68ccef4b59b8f0513d6a74d706
71 schema:url https://www.nature.com/articles/bjc2016430
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N0cdd54ae26c5451c88ad5c68f3b766ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Chemotherapy, Adjuvant
77 rdf:type schema:DefinedTerm
78 N106b37e697f642e082502d95c78a216c rdf:first sg:person.01130363736.78
79 rdf:rest N2df02c55a44844e39f710bc545064277
80 N29560904ebd8476cb2861ddab614f621 rdf:first sg:person.01310114005.83
81 rdf:rest Ne851728d16d8430983f03570fdb958b5
82 N2ab16bc2f2ab4bdcb7d52cad7888cd81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Treatment Outcome
84 rdf:type schema:DefinedTerm
85 N2b00b32909884e3685d2c9aa9b736fa2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Carcinoma, Endometrioid
87 rdf:type schema:DefinedTerm
88 N2df02c55a44844e39f710bc545064277 rdf:first sg:person.0771464734.13
89 rdf:rest N832e7d6848bb416f82d51f5b1e5f3ee4
90 N30fcd864eca843b190674d34f61f451b schema:name ICO centre René Gauducheau, Boulevard Jacques Monod, 44805 Saint Herblain, France.
91 rdf:type schema:Organization
92 N3dc83bad442343a29354c6ada30304be rdf:first sg:person.01130240530.48
93 rdf:rest N29560904ebd8476cb2861ddab614f621
94 N405fa3e49e924f8ba60c4a944f8364e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Female
96 rdf:type schema:DefinedTerm
97 N41fac904ae9e4f459763e03b3bd32356 rdf:first sg:person.0603333673.39
98 rdf:rest N3dc83bad442343a29354c6ada30304be
99 N59948e06cd1046f49a3755942df122ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Aged
101 rdf:type schema:DefinedTerm
102 N5f47416f476f4e719da5f30f700ea84a rdf:first sg:person.01302261163.11
103 rdf:rest Na119bbccd45541b2b03fb11b62b61ae1
104 N61353444f24f42c5932ce41c3375c38e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Aminopyridines
106 rdf:type schema:DefinedTerm
107 N623dc783a4414aa49f769fc2afb7ebf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N62bbe598cdce410db82d04fbfe33862e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Phosphatidylinositol 3-Kinases
112 rdf:type schema:DefinedTerm
113 N6326b10f76654966b4a8a28d3125f263 schema:name pubmed_id
114 schema:value 28072765
115 rdf:type schema:PropertyValue
116 N63469cdf19f04fd5a685bd16cd2ddcb4 schema:name nlm_unique_id
117 schema:value 0370635
118 rdf:type schema:PropertyValue
119 N6b581f54378e4847a87673cd1f159c8c schema:volumeNumber 116
120 rdf:type schema:PublicationVolume
121 N7506cab6906b40b3803007ff8be7aac6 rdf:first sg:person.01176376555.98
122 rdf:rest Na127d136be2f4aef8170e85e7e0e7063
123 N7ddff22fdad74590a01605bc9f480897 rdf:first sg:person.0770700432.69
124 rdf:rest N106b37e697f642e082502d95c78a216c
125 N8282e895d9fa4d898d0799e4ae8e8f0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Endometrial Neoplasms
127 rdf:type schema:DefinedTerm
128 N832e7d6848bb416f82d51f5b1e5f3ee4 rdf:first sg:person.01210131470.86
129 rdf:rest N9f59a0b3da07441b9cb1a0b6d797c990
130 N89bc596d3c064d35b443a68b581e3612 rdf:first sg:person.0673616572.83
131 rdf:rest N7506cab6906b40b3803007ff8be7aac6
132 N8fbbb550cbf645d7b674114a481b7db1 rdf:first sg:person.01303347205.28
133 rdf:rest Nb38c3f7e48e343a6972aa75245704c89
134 N9358172417c44cffac76a24eddcad0db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Antineoplastic Agents
136 rdf:type schema:DefinedTerm
137 N97bb830d4a784b4286a8d311282074a1 rdf:first sg:person.01040472216.86
138 rdf:rest Na9ce404e1f584a5e9ec00e4d5260afef
139 N9924032479434462a6ce29411a60332f schema:issueNumber 3
140 rdf:type schema:PublicationIssue
141 N9b4e04e8a5c14c37b1f3d7f79b482d3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Middle Aged
143 rdf:type schema:DefinedTerm
144 N9f59a0b3da07441b9cb1a0b6d797c990 rdf:first sg:person.01011732622.02
145 rdf:rest rdf:nil
146 N9f59f194ce3f4f53a2db1a8ea5d50763 schema:name doi
147 schema:value 10.1038/bjc.2016.430
148 rdf:type schema:PropertyValue
149 Na119bbccd45541b2b03fb11b62b61ae1 rdf:first sg:person.01160553765.04
150 rdf:rest N8fbbb550cbf645d7b674114a481b7db1
151 Na127d136be2f4aef8170e85e7e0e7063 rdf:first sg:person.0725456003.16
152 rdf:rest N41fac904ae9e4f459763e03b3bd32356
153 Na25a5a62f5254aa4b294389e97324cc6 rdf:first sg:person.01046414414.62
154 rdf:rest N89bc596d3c064d35b443a68b581e3612
155 Na810dc387ef34b0dab8bb1d5da1f89b9 rdf:first sg:person.0602102643.67
156 rdf:rest Nb676b403ef944c5ea55b561f81f278e4
157 Na9ce404e1f584a5e9ec00e4d5260afef rdf:first sg:person.0653052265.95
158 rdf:rest N5f47416f476f4e719da5f30f700ea84a
159 Naca1a78b2ed3441f9c471153ff5642e8 schema:name dimensions_id
160 schema:value pub.1049733476
161 rdf:type schema:PropertyValue
162 Nb38c3f7e48e343a6972aa75245704c89 rdf:first sg:person.0723166073.42
163 rdf:rest Na810dc387ef34b0dab8bb1d5da1f89b9
164 Nb676b403ef944c5ea55b561f81f278e4 rdf:first sg:person.0676173315.81
165 rdf:rest N7ddff22fdad74590a01605bc9f480897
166 Nb6788536af544a30bccf3a9a616209f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Disease Progression
168 rdf:type schema:DefinedTerm
169 Nb685ab5a2df44dc394af6244ca9376e9 schema:name ORACLE Centre d'oncologie de Gentilly, 2 Rue Marie Marvingt, 54100 Nancy, France.
170 rdf:type schema:Organization
171 Nc1af2d68ccef4b59b8f0513d6a74d706 schema:name Springer Nature - SN SciGraph project
172 rdf:type schema:Organization
173 Nc28dafc75bd74ff289f68f90833e5675 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Aged, 80 and over
175 rdf:type schema:DefinedTerm
176 Nc4fdefc8f5ae4a29966f5469e03698fe schema:name readcube_id
177 schema:value ece9ddc00c1fa6bad3cf389cff939c16ab9c66c7aa820a428d8d3056dbbfac5a
178 rdf:type schema:PropertyValue
179 Nc5dd7ebd21764dee8565b5774905deb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Recurrence
181 rdf:type schema:DefinedTerm
182 Nc68075646e974580b71cc8d41d6c42dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Neoplasm Recurrence, Local
184 rdf:type schema:DefinedTerm
185 Ne006044d930f49d4b6621d59682b0310 schema:name Centre hospitalier départemental Les Oudairies, Les Oudairies, 85925 La Roche-sur-Yon, France.
186 rdf:type schema:Organization
187 Ne851728d16d8430983f03570fdb958b5 rdf:first sg:person.0713113255.12
188 rdf:rest N97bb830d4a784b4286a8d311282074a1
189 Nf270d8e8e2bd4cc38192a2118d6b05e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Morpholines
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
196 schema:name Clinical Sciences
197 rdf:type schema:DefinedTerm
198 sg:journal.1017082 schema:issn 0007-0920
199 1532-1827
200 schema:name British Journal of Cancer
201 rdf:type schema:Periodical
202 sg:person.01011732622.02 schema:affiliation https://www.grid.ac/institutes/grid.7849.2
203 schema:familyName Ray-Coquard
204 schema:givenName I
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011732622.02
206 rdf:type schema:Person
207 sg:person.01040472216.86 schema:affiliation https://www.grid.ac/institutes/grid.418122.c
208 schema:familyName Foa
209 schema:givenName C
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040472216.86
211 rdf:type schema:Person
212 sg:person.01046414414.62 schema:affiliation https://www.grid.ac/institutes/grid.462282.8
213 schema:familyName Heudel
214 schema:givenName P-E
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046414414.62
216 rdf:type schema:Person
217 sg:person.01130240530.48 schema:affiliation https://www.grid.ac/institutes/grid.476192.f
218 schema:familyName Joly
219 schema:givenName F
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130240530.48
221 rdf:type schema:Person
222 sg:person.01130363736.78 schema:affiliation https://www.grid.ac/institutes/grid.490056.e
223 schema:familyName Lortholary
224 schema:givenName A
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130363736.78
226 rdf:type schema:Person
227 sg:person.01160553765.04 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
228 schema:familyName Tazi
229 schema:givenName Y
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160553765.04
231 rdf:type schema:Person
232 sg:person.01176376555.98 schema:affiliation Nb685ab5a2df44dc394af6244ca9376e9
233 schema:familyName Roemer-Becuwe
234 schema:givenName C
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176376555.98
236 rdf:type schema:Person
237 sg:person.01210131470.86 schema:affiliation https://www.grid.ac/institutes/grid.462282.8
238 schema:familyName Treilleux
239 schema:givenName I
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210131470.86
241 rdf:type schema:Person
242 sg:person.01302261163.11 schema:affiliation Ne006044d930f49d4b6621d59682b0310
243 schema:familyName Priou
244 schema:givenName F
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302261163.11
246 rdf:type schema:Person
247 sg:person.01303347205.28 schema:affiliation https://www.grid.ac/institutes/grid.476460.7
248 schema:familyName Floquet
249 schema:givenName A
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303347205.28
251 rdf:type schema:Person
252 sg:person.01310114005.83 schema:affiliation https://www.grid.ac/institutes/grid.477089.5
253 schema:familyName Roche-Forestier
254 schema:givenName S
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310114005.83
256 rdf:type schema:Person
257 sg:person.0602102643.67 schema:affiliation N30fcd864eca843b190674d34f61f451b
258 schema:familyName Berton-Rigaud
259 schema:givenName D
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602102643.67
261 rdf:type schema:Person
262 sg:person.0603333673.39 schema:affiliation https://www.grid.ac/institutes/grid.482015.a
263 schema:familyName Arnaud
264 schema:givenName A
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603333673.39
266 rdf:type schema:Person
267 sg:person.0653052265.95 schema:affiliation https://www.grid.ac/institutes/grid.411430.3
268 schema:familyName You
269 schema:givenName B
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653052265.95
271 rdf:type schema:Person
272 sg:person.0673616572.83 schema:affiliation https://www.grid.ac/institutes/grid.418189.d
273 schema:familyName Fabbro
274 schema:givenName M
275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673616572.83
276 rdf:type schema:Person
277 sg:person.0676173315.81 schema:affiliation https://www.grid.ac/institutes/grid.452351.4
278 schema:familyName Lesoin
279 schema:givenName A
280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676173315.81
281 rdf:type schema:Person
282 sg:person.0713113255.12 schema:affiliation https://www.grid.ac/institutes/grid.413932.e
283 schema:familyName Meunier
284 schema:givenName J
285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713113255.12
286 rdf:type schema:Person
287 sg:person.0723166073.42 schema:affiliation https://www.grid.ac/institutes/grid.413483.9
288 schema:familyName Selle
289 schema:givenName F
290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723166073.42
291 rdf:type schema:Person
292 sg:person.0725456003.16 schema:affiliation https://www.grid.ac/institutes/grid.452436.2
293 schema:familyName Kaminsky
294 schema:givenName M C
295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725456003.16
296 rdf:type schema:Person
297 sg:person.0770700432.69 schema:affiliation https://www.grid.ac/institutes/grid.411158.8
298 schema:familyName Kalbacher
299 schema:givenName E
300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770700432.69
301 rdf:type schema:Person
302 sg:person.0771464734.13 schema:affiliation https://www.grid.ac/institutes/grid.418037.9
303 schema:familyName Favier
304 schema:givenName L
305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771464734.13
306 rdf:type schema:Person
307 sg:pub.10.1007/s11523-012-0242-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031547406
308 https://doi.org/10.1007/s11523-012-0242-9
309 rdf:type schema:CreativeWork
310 sg:pub.10.1038/bjc.2013.183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041756285
311 https://doi.org/10.1038/bjc.2013.183
312 rdf:type schema:CreativeWork
313 sg:pub.10.1038/bjc.2013.59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042426230
314 https://doi.org/10.1038/bjc.2013.59
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1002/cncr.25515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012105008
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1002/ijc.25516 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008443664
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1006/gyno.2000.5865 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005662943
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1016/0197-2456(89)90015-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053744925
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1016/j.humpath.2010.01.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007351676
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1016/j.ygyno.2008.01.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034647261
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1016/j.ygyno.2010.08.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050434269
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1016/j.ygyno.2014.01.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025790666
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1016/j.ygyno.2014.06.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016795262
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1016/j.ygyno.2014.12.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009130095
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1016/s0020-7292(06)60031-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045288298
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1016/s1470-2045(13)70591-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037614110
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1093/annonc/mdl417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035040603
341 rdf:type schema:CreativeWork
342 https://doi.org/10.1093/jnci/92.11.861 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049096878
343 rdf:type schema:CreativeWork
344 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
345 rdf:type schema:CreativeWork
346 https://doi.org/10.1097/jto.0000000000000607 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006459485
347 rdf:type schema:CreativeWork
348 https://doi.org/10.1111/j.1525-1438.2007.00897.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025011674
349 rdf:type schema:CreativeWork
350 https://doi.org/10.1136/jcp.2008.056101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049314556
351 rdf:type schema:CreativeWork
352 https://doi.org/10.1158/1078-0432.ccr-10-0540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007254509
353 rdf:type schema:CreativeWork
354 https://doi.org/10.1200/jco.2010.34.1578 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036050400
355 rdf:type schema:CreativeWork
356 https://doi.org/10.1200/jco.2011.36.1360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045236478
357 rdf:type schema:CreativeWork
358 https://doi.org/10.1200/jco.2011.39.0708 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046132060
359 rdf:type schema:CreativeWork
360 https://doi.org/10.1200/jco.2013.54.0518 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038582973
361 rdf:type schema:CreativeWork
362 https://doi.org/10.1200/jco.2014.58.3401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007930689
363 rdf:type schema:CreativeWork
364 https://doi.org/10.1200/jco.2014.58.8871 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022817141
365 rdf:type schema:CreativeWork
366 https://doi.org/10.3747/co.22.2393 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001818806
367 rdf:type schema:CreativeWork
368 https://doi.org/10.3892/ijo.25.6.1615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071515520
369 rdf:type schema:CreativeWork
370 https://www.grid.ac/institutes/grid.14925.3b schema:alternateName Institut Gustave Roussy
371 schema:name Institut de cancérologie Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif, France.
372 rdf:type schema:Organization
373 https://www.grid.ac/institutes/grid.411158.8 schema:alternateName Centre Hospitalier Universitaire de Besançon
374 schema:name Hôpital Jean Minjoz, 3 Boulevard Alexandre Fleming, 25030 Besançon, France.
375 rdf:type schema:Organization
376 https://www.grid.ac/institutes/grid.411430.3 schema:alternateName Centre Hospitalier Lyon Sud
377 schema:name Centre hospitalier Lyon Sud, 165 Chemin du Grand Revoyet, 69495 Pierre-Bénite, France.
378 rdf:type schema:Organization
379 https://www.grid.ac/institutes/grid.413483.9 schema:alternateName Tenon Hospital
380 schema:name Hôpital Tenon, 4 rue de la Chine 75020 Paris, France.
381 rdf:type schema:Organization
382 https://www.grid.ac/institutes/grid.413932.e schema:alternateName Centre hospitalier régional d'Orléans
383 schema:name Centre hospitalier régional d'Orléans, 14 Avenue de l'Hôpital, 45067 Orléans, France.
384 rdf:type schema:Organization
385 https://www.grid.ac/institutes/grid.418037.9 schema:alternateName Centre Georges François Leclerc
386 schema:name Centre Georges François Leclerc, 1 Rue Professeur Marion, 21079 Dijon, France.
387 rdf:type schema:Organization
388 https://www.grid.ac/institutes/grid.418122.c schema:alternateName Hôpital privé Clairval
389 schema:name Hôpital privé Clairval, 317 Boulevard du Redon, 13009 Marseille, France.
390 rdf:type schema:Organization
391 https://www.grid.ac/institutes/grid.418189.d schema:alternateName UniCancer Group
392 schema:name ICM Val d'Aurelle, Parc Euromédecine 208 Rue des Apothicaires, 34298 Montpellier, France.
393 rdf:type schema:Organization
394 https://www.grid.ac/institutes/grid.452351.4 schema:alternateName Centre Oscar Lambret
395 schema:name Centre Oscar Lambret, 3 Rue F. Combemale, 59020 Lille, France.
396 rdf:type schema:Organization
397 https://www.grid.ac/institutes/grid.452436.2 schema:alternateName Institut de Cancérologie de Lorraine
398 schema:name ICL Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne Brabois, 54511 Vandoeuvre-les-Nancy, France.
399 rdf:type schema:Organization
400 https://www.grid.ac/institutes/grid.462282.8 schema:alternateName Cancer Center of Lyon
401 schema:name Department of Medical Oncology, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 28 Rue Laennec, 69008 Lyon, France.
402 rdf:type schema:Organization
403 https://www.grid.ac/institutes/grid.476192.f schema:alternateName Centre Franois Baclesse
404 schema:name Centre François Baclesse, Avenue du Général Harris, 14000 Caen, France.
405 rdf:type schema:Organization
406 https://www.grid.ac/institutes/grid.476460.7 schema:alternateName Institut Bergonié
407 schema:name Institut Bergonié, 229 Cours de l'Argonne, 33076 Bordeaux, France.
408 rdf:type schema:Organization
409 https://www.grid.ac/institutes/grid.477089.5 schema:alternateName Centre Jean Bernard
410 schema:name Centre Jean Bernard-Clinique Victor Hugo, 18 Rue Victor Hugo, 72000 Le Mans, France.
411 rdf:type schema:Organization
412 https://www.grid.ac/institutes/grid.482015.a schema:alternateName Institut Sainte Catherine
413 schema:name Institut Sainte Catherine, 250 Chemin de Baigne-pieds, 84918 Avignon, France.
414 rdf:type schema:Organization
415 https://www.grid.ac/institutes/grid.490056.e schema:alternateName Confluent Private Hospital
416 schema:name Centre Catherine de Sienne, 2 Rue Eric Tabarly, 44202 Nantes, France.
417 rdf:type schema:Organization
418 https://www.grid.ac/institutes/grid.7849.2 schema:alternateName Claude Bernard University Lyon 1
419 schema:name Department of Medical Oncology, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 28 Rue Laennec, 69008 Lyon, France.
420 UCBL Université Claude Bernard, Lyon I, Lyon, France.
421 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...